PriceTracker GLP-1
Loading the index…

Try

Loading the index…

Try

GLP-1 TV · Patient story · views checked Oct 2026

18 MONTHS ON MOUNJARO | side effects, before pics, weight loss update & plans to stop?

Patient storyBabbling by the Brook29,489 views18:12May 2026

Our summary

Helen, a 37-year-old creator who says she is not medically trained, gives an update after about 18 months on Mounjaro, which she started around the end of September or beginning of October 2024. She says she has lost 14.5 kg in total. She is 4'11 and has lymphedema and lipedema, and she says her symptoms from both conditions have eased, with her legs feeling less heavy, although the lipedema has not gone away. She says she had been stuck at Slimming World for about a year before starting, and that she gets her medication through MedExpress.

One person's experience, in their words. Not medical advice.

What else the video covers

On dosing, she says she started on 2.5 mg for around 3 to 4 months, then moved to 5 mg, where she found the appetite suppression too strong. She stresses that a person should still feel hungry on the medication and says reduced food noise is different from never feeling hungry. She reports no hair loss, only mild constipation at the start that she links to hydration, a brief aversion to coffee and eggs early on, and improved digestion since. She injects into her stomach, alternating sides weekly, and takes vitamin D and calcium. She does not count calories and says she eats smaller portions and wants less alcohol, without cutting foods out.

She says she is currently maintaining her weight and is comfortable with it. She has no plans to stop Mounjaro soon and says she is nervous that cravings and symptom relief could return. She says she has not looked into switching to a cheaper option but is not opposed to it. For viewers struggling after a dose increase, she suggests contacting their provider for advice.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 1:02 Helen says she started in late September or early October 2024 and has lost 14.5 kg over about 18 months.
  2. 3:30 She says her lymphedema and lipedema symptoms have eased, with less swelling and lighter legs, though the lipedema remains.
  3. 5:09 She says she began on 2.5 mg for 3 to 4 months, moved to 5 mg, and found the suppression too strong, stressing that people should still feel hungry.
  4. 8:45 She reports no real side effects beyond mild early constipation and a brief food aversion, and says her digestion has improved.
  5. 9:45 She says she is now maintaining her weight and is content with it.
  6. 13:16 She says she does not count calories, eats smaller portions intuitively, and cuts nothing out of her diet.

Key moments

From the creator's own chapters. Tap one to play from there.

  1. 0:00 Introduction
  2. 1:01 Weight loss journey overview
  3. 3:27 Benefits and provider info
  4. 4:54 Mounjaro experience
  5. 7:17 Long-term outlook and side effects
  6. 9:34 Maintaining weight
  7. 10:19 Style and self-confidence
  8. 12:12 Supplements and injection site

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Wegovy and Mounjaro
Doses mentioned
2.5 mg and 5 mg
Point in the journey
Month 18
Side effects mentioned
constipation, loose skin or face changes and low appetite
Who is speaking
Patient

Questions this video answers

How much weight did Helen lose in 18 months on Mounjaro?

She says she has lost 14.5 kg in just over 18 months, starting around the end of September or beginning of October 2024. She is 4'11 and says she is now maintaining that weight.

What Mounjaro doses did Helen take?

She says she started on 2.5 mg for about 3 to 4 months, then increased to 5 mg. She says she found the suppression at the higher dose a bit too strong and stresses that people should still feel hungry.

What side effects does Helen report on Mounjaro?

She says she has had no bad side effects, only a little constipation at the start that she links to staying hydrated. She also mentions going off coffee after her first dose and off eggs early on, and says she has not lost any hair.

Does Helen plan to come off Mounjaro?

She says she has no plans to stop soon. She says she would talk to her provider first and is nervous about cravings and symptom relief returning.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

About Babbling by the Brook

Patient story, 21.1K subscribers. 6 of their videos are in GLP-1 TV, 517K views between them, mostly on Mounjaro.

Every Babbling by the Brook video

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Mounjaro for weight loss, and why Zepbound exists

    Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.

  • Mounjaro side effects: the label's numbers by dose, the low blood sugar risk, and how tirzepatide compares at weight-loss doses

    On Mounjaro's own label, the common side effects are stomach ones and they rise with the dose: nausea in 12, 15 and 18 percent of people at 5, 10 and 15 mg against 4 percent on placebo, diarrhea 12 to 17 against 9, and any gastrointestinal reaction in 37 to 44 percent against 20. Most of it happens while the dose is being raised and fades. Low blood sugar is rare on Mounjaro alone and is mainly a risk when it is added to insulin or a sulfonylurea. Below: the full table, the rare warnings, and why Zepbound's numbers for the same molecule look higher.

  • Mounjaro vs Ozempic, and the trial everyone quotes about it

    Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.

Find more like it

Side effectsDose changeFood, protein and eatingFood noise and cravingsMood and mental healthExercise and strengthStopping and maintenanceConstipationLoose skin or face changesLow appetite

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV